Clinical Trials

28 enrolled

Radiation Injuries, Sarcoma

NCT05253131 2026-02-11

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

41 enrolled

CNSSarcoma

Neurofibromatosis 1, Sarcoma, Neurofibrosarcoma

NCT07401355 2026-02-10

LIGHT-CTC

100 enrolled

Neoplasms, Sarcoma

NCT06712433 2026-02-09

CONCERTO

31 enrolled

Phase EARLY_PHASE1 Not yet recruiting

NCT07389525 2026-02-05

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

80 enrolled

DermatologicGastrointestinalSarcoma

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

NCT07342322 2026-01-15

A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma

25 enrolled

Phase 1 Not yet recruiting

NCT07054944 2025-12-15

T-LyM

10 enrolled

Phase 1 Not yet recruiting

Neoplasms, Neoplasms, Germ Cell and Embryonal, Rhabdomyosarcoma, Sarcoma

NCT07027423 2025-12-01

BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas

32 enrolled

NCT07205185 2025-10-03

A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.

46 enrolled

Phase EARLY_PHASE1 Not yet recruiting

NCT07104682 2025-08-05

CLIC-YYC-GPNMB

1 enrolled

Sarcoma, Sarcoma, Alveolar Soft Part

NCT07048184 2025-07-09

SUNDIAL

94 enrolled

NCT06500715 2025-05-16

Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma

Classical hematologySarcoma

60 enrolled

Cross Infection, Sarcoma, Febrile Neutropenia

NCT06887673 2025-03-20

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

Phase EARLY_PHASE1 Not yet recruiting

56 enrolled

CNSGastrointestinalGynecologicSarcoma

Brain Neoplasms, Inflammation, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms

NCT06476704 2025-02-04

PRACTISS

42 enrolled

Hypoxia, Sarcoma

NCT06726512 2024-12-10

qMAP

30 enrolled

Head & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms, Sarcoma, Osteosarcoma

NCT06694324 2024-11-19

First-line Treatment of Advanced/unresectable DDLPS

49 enrolled

Phase 3 Not yet recruiting

Liposarcoma, Sarcoma

NCT06480396 2024-10-16

SARveillance

584 enrolled

NCT06565858 2024-09-20

Physical Activity and Sarcoma, Role and Impact on Outcome

Not yet recruiting

750 enrolled

Motor Activity, Sarcoma

NCT06550765 2024-08-13

Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors

98 enrolled

NCT06551896 2024-08-13

Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor

BreastGastrointestinalGenitourinarySarcomaThoracic

30 enrolled

Breast Neoplasms, Carcinoma, Carcinoma, Transitional Cell, Lung Neoplasms, Sarcoma, Stomach Neoplasms

NCT04889742 2023-12-26

HETERERO